Intco Medical Technology Co., Ltd.
300677
Rangering i aksjer
#3956
Intco Medical Technology Co., Ltd. is a company dedicated to the development,... Intco Medical Technology Co., Ltd. is a company dedicated to the development, manufacturing, and worldwide distribution of both single-use medical products and durable medical equipment, serving markets within China and internationally. Their extensive product portfolio includes a variety of personal protective equipment like gloves, face masks, and shields, as well as essential clinical supplies such as ECG electrodes, medical apparel (e.g., isolation gowns), and hand hygiene solutions in both gel and spray forms. The company also produces specialized surgical components, including grounding pads, electrosurgical pencils, ESU cables, tip cleaners, and TENS electrodes. Beyond disposables, Intco Medical supplies a range of robust medical devices, notably mobility aids such as wheelchairs and scooters, along with other general medical apparatus. Their offerings further extend to temperature therapy items, emergency treatment provisions, products for maternal and infant care, and various home healthcare solutions. Established in 2009 and headquartered in Zibo, China, the company underwent a formal corporate name update in January 2020, maintaining its designation as Intco Medical Technology Co., Ltd.
Aksjekurs
$6.36
Markedsverdi
$4.16B
Endring (1 dag)
-0.12%
Endring (1 år)
8.75%
Land
CN
Handel Intco Medical Technology Co., Ltd. (300677)
Kategori
Healthcare
Inntekter for Intco Medical Technology Co., Ltd. (300677)
Inntekter i Jun 2026 TTM: $215.90M
Ifølge Intco Medical Technology Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat $215.90M. I 2023 hadde selskapet et resultat på $62.56M, en nedgang sammenlignet med resultatet i 2022, som var $102.12M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Intco Medical Technology Co., Ltd. fra 2013 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $215.90M | -2.05% |
| 2024 | $220.43M | 252.36% |
| 2023 | $62.56M | -38.74% |
| 2022 | $102.12M | -92.50% |
| 2021 | $1.36B | 6.50% |
| 2020 | $1.28B | 4,276.77% |
| 2019 | $29.19M | -2.81% |
| 2018 | $30.04M | 20.00% |
| 2017 | $25.03M | 77.48% |
| 2016 | $14.10M | 23.57% |
| 2015 | $11.41M | 89.37% |
| 2014 | $6.03M | 240.50% |
| 2013 | $1.77M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $3.81B | 1,662.73% |
US
|
|
| $4.11B | 1,803.09% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 636.44% |
US
|
|
| - | - |
CH
|
